Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPV1 is a non-selective cation channel that acts as a detector of noxious heat, acidic conditions, capsaicin, and other stimuli. It plays a key role in pain sensation and is predominantly expressed in peripheral nociceptive sensory neurons. Altered TRPV1 function is linked to chronic pain states, making it a therapeutic target for analgesics. Activation leads to influx of cations, primarily Ca2+ and Na+, causing depolarization and pain signal propagation. It can be activated/sensitized by exogenous activators like capsaicin and endogenous modulators such as protons and endocannabinoids. Inflammatory mediators also sensitize the receptor, contributing to hyperalgesia and allodynia. The channel has a tetrameric structure with each subunit containing six transmembrane domains. Cryo-electron microscopy reveals its fourfold symmetry and cytoplasmic basket-like domains.
Influx of cations (Ca2+, Na+) leading to depolarization of sensory neurons and propagation of pain signals; Sensitization by pro-inflammatory mediators (prostaglandins, bradykinin, NGF, ATP)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient Receptor Potential Vanilloid Type 1 (TRPV1).